Pricing Log in Create free account

Karyopharm Therapeutics Inc. (KPTI) vs Oragenics, Inc. (OGEN)

Karyopharm Therapeutics Inc. and Oragenics, Inc. are both Biotechnology companies. Oragenics, Inc. is the larger, with a market value of $1.6M against $1.4M — 1.2× the size. Karyopharm Therapeutics Inc. grew revenue faster over the last twelve months: 6.81% against −75.1%. Oragenics, Inc. has the higher net margin (0.00% vs −153.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Karyopharm Therapeutics Inc. leads on 8 and Oragenics, Inc. on 8.

Valuation

Metric KPTI OGEN Biotechnology median
P/E n/m n/m 10.60
P/S 0.01 12.53 9.40
P/B n/m 0.42 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 1.27 0.69 9.02
Earnings yield (25,680.00%) (982.63%) (32.88%)
Free cash flow yield (4,526.16%) (656.98%) (23.13%)

Profitability

Metric KPTI OGEN Biotechnology median
Gross margin 95.89% 19.89% 68.51%
Operating margin (56.17%) 0.00% 0.00%
Net margin (153.28%) 0.00% 0.00%
Free cash flow margin (44.57%) 0.00% 0.00%
Return on equity 78.98% (1,307.07%) (51.96%)
Return on assets (207.90%) (264.23%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric KPTI OGEN Biotechnology median
Revenue growth (TTM) 6.81% (75.08%) 6.76%
EPS growth (last fiscal year) (28.07%) 90.51% 29.88%
Revenue growth, 5-year CAGR 6.21% (50.98%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric KPTI OGEN Biotechnology median
Debt to equity (0.76) 0.00 0.00
Current ratio 0.79 3.01 4.97
Net debt to EBITDA (2.03) 0.98 1.01

Dividend

Metric KPTI OGEN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric KPTI OGEN Biotechnology median
Market cap 1.36m 1.58m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack